Fruquintinib Combined With Chemotherapy

DRUG2 trials

Sponsors

Zhejiang Cancer Hospital, The Methodist Hospital Research Institute

Conditions

Advanced Colorectal CancerMetastatic Colorectal Cancer (CRC)

Phase 2

Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer

RecruitingNCT07042685

The Methodist Hospital Research InstituteMetastatic Colorectal Cancer (CRC)

Start: 2026-01-27End: 2029-12-01Target: 50Updated: 2026-04-09

Unknown Phase

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

Not yet recruitingNCT05928312

Zhejiang Cancer HospitalAdvanced Colorectal Cancer

Start: 2023-08-28End: 2026-06-01Target: 72Updated: 2023-07-20